Latest Quarter
Q2 FY2026ended 2026-06-30 · filed 2026-08-05
$70.51M
$-7.16M
$-4.07M
-$0.30
$17M
$511.39M
$343.61M
$105.75M
What this quarter tells us
For Q1 FY2026 ended March 31, 2026, OrthoPediatrics reported revenue of $59.4 million, up 13.3% year-over-year. Net loss was $10.7 million, slightly wider than the prior year's $10.6 million loss. Operating loss improved 24.1% to $8.3 million. Diluted EPS was -$0.45, compared to -$0.46 a year ago.
- •Revenue grew 13.3% YoY to $59.4 million.
- •Net loss was $10.7 million, essentially flat YoY.
- •Operating loss narrowed 24.1% to $8.3 million.
- •Diluted EPS improved to -$0.45 from -$0.46.
Informational summary based on SEC XBRL figures · generated by deepseek-v4-flash. Not investment advice.